US Patent 11040034 Metalloenzyme inhibitor compounds
Patent 11040034 was granted and assigned to Phasebio Pharmaceuticals, Inc. on June, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11040034 Metalloenzyme inhibitor compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
